Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.
Open | $3.690 |
Close | $3.840 |
Volume / Avg. | 141.632K / 306.941K |
Day Range | 3.645 - 3.920 |
52 Wk Range | 1.810 - 11.310 |
Market Cap | $232.869M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 2.07% |
Days to Cover | 3.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and Agenus (NASDAQ:AGEN).
The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 15.00 expecting ABOS to rise to within 12 months (a possible 287.00% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $3.876 last updated May 20, 2024 at 7:37 AM EDT.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.